K.M. Broadway & Scharf B.E. (2019) Salmonella Typhimurium as an anticancer therapy: recent advances and perspectives. Current Clinical Microbiology Reports 6(4), 225-239.
K.M. Broadway, Suh S., Behkam B, Scharf B.E. (2017) Optimizing the restored chemotactic behavior of anticancer agent Salmonella enterica serovar Typhimurium VNP20009. Journal of Biotechnology 251, 76-83. ( DOI: 10.1016/j.jbiotec.2017.04.006)
S.L. Coutermarsh-Ott, Broadway K.M., Scharf B.E., Allen I.C. of Salmonella enterica serovar Typhimurium VNP20009 and VNP20009 with restored chemotaxis on 4T1 mouse mammary carcinoma progression. (2017) Oncotarget, 8(20), 33601-33613. (DOI: 10.18632/oncotarget.16830)
K.M. Broadway, Denson E.A., Jensen R.V., Scharf B.E. (2015) Rescuing chemotaxis of the anticancer agent Salmonella enterica serovar Typhimurium VNP20009. Journal of Biotechnology 211, 117-120. (DOI:10.1016/j.jbiotec.2014.07.006)
K.M. Broadway, Modise T., Jensen R.V., Scharf B.E. (2014) Complete Genome Sequence of Salmonella enterica serovar Typhimurium VNP20009, a strain engineered for tumor targeting. Journal of Biotechnology 192, 177-178. (DOI:10.1016/j.jbiotec.2015.07.010)